MobiHealth News March 23, 2021
The pilot study in north-east England will pioneer a personalised medicine approach.
UK biotech firm Genomics plc is working with the NHS on a pilot study using genetic information to predict patients’ risk of heart disease.
Around 1,000 people in north-east England who attend routine GP health checks, will take part in the trial.
An integrated risk tool (IRT), created by Oxford University spin-off Genomics plc, will be used to estimate each patient’s risk of developing cardiovascular disease (CVD) within the next 10 years.
Patient blood samples will be analysed to calculate a polygenic risk score (PRS), combing information from thousands of individual genetic variants to indicate an individual’s predisposition to disease.
This score is then added...
Today's Sponsors
Today's Sponsor